Improving prevention and treatment strategies for cardiomyopathy patients
Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH Trial): a National Multi-center, Retrospective-prospective, Cohort Study
This study is trying to gather information from cardiomyopathy patients to find better ways to prevent and treat their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | First Affiliated Hospital Xi'an Jiaotong University Academic / other |
| Locations | 1 site (Xi'an, Shaanxi) |
| Trial ID | NCT06352320 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a natural population cohort of patients with various types of cardiomyopathy by enrolling participants from multiple centers. It will collect clinical data and biological samples from surgical patients to develop a prognostic system for cardiomyopathy. The study seeks to optimize risk stratification and explore new strategies for early prevention and treatment, ultimately enhancing the diagnosis and treatment efficiency for cardiomyopathy patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old with a confirmed diagnosis of cardiomyopathy.
Not a fit: Patients with incomplete clinical data or those who do not consent to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early prevention and treatment strategies for patients with cardiomyopathy.
How similar studies have performed: While there have been studies focusing on cardiomyopathy, this approach of creating a comprehensive prognostic system is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years old. * The diagnosis of cardiomyopathy was confirmed by cardiac ultrasound, electrocardiogram, magnetic resonance angiography, pathological examination and gene sequencing. * Patients or their families agreed to participate in the study and authorized informed consent. Exclusion Criteria: * Incomplete clinical data. * Do not agree to the inclusion or refuse to authorize the informed consent.
Where this trial is running
Xi'an, Shaanxi
- First Affiliated Hospital of Xi'an Jiantong University — Xi'an, Shaanxi, China (Recruiting)
Study contacts
- Principal investigator: Yang Yan — First Affiliated Hospital Xi'an Jiaotong University
- Study coordinator: Yang Yan
- Email: yangyan3@xjtu.edu.cn
- Phone: +862985323869
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.